APLNR and cancer: Alteration of apelin cleavage sites generates apelin-dm peptide that effectively represses the malignant and metastatic phenotype of cancer cells and angiogenesis through modulation of apelin receptor dynamics, affinity, internalization, and diverse apelin signaling pathways.